Xconomy: Onyx Gets FDA Approval For New Myeloma Drug; Stock Climbs

E-mail a copy of 'Onyx Gets FDA Approval For New Myeloma Drug; Stock Climbs' to a friend

Loading ...

Underwriters and Partners

Xpertise: Watch + Learn

Sponsored · Whitepaper

Monitoring Solutions for Pharma-CRO/CMO Partnerships to Maintain Quality & Timelines

Implementing electronic solutions for risk mitigation
XiltriX

Xconomy Insight · Special Report

How to Jump 5 Unforeseen Hurdles to Biotech Success – Startup Sourcebook

Insights, wisdom, and inspiration on what it takes

Xconomy Insight · Webinar

The New Era of Emerging Therapies Webinar Series

Potential cures and treatments for diseases are on the horizon for a growing number of patients, thanks to recent breakthroughs in CRISPR gene-editing technologies and in cell and gene therapy.

From Our Advertisers

Investment in Wisconsin startups reaches new record total

Tax credits help tech innovators attract capital, fuel growth
Wisconsin Economic Development Corporation

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

IDG Tech Network

Protected by Carbonite

Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit/Ann Arbor, San Francisco, New York, Raleigh-Durham, Boulder/Denver, Texas, Wisconsin, Indiana, and beyond.

© 2007-2019, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.